GIAQUINTO, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 22.815
AS - Asia 2.332
EU - Europa 2.321
AF - Africa 49
OC - Oceania 15
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 27.543
Nazione #
US - Stati Uniti d'America 22.781
SG - Singapore 1.127
CN - Cina 926
IT - Italia 679
FI - Finlandia 488
FR - Francia 314
GB - Regno Unito 216
SE - Svezia 198
DE - Germania 179
VN - Vietnam 159
UA - Ucraina 87
IE - Irlanda 63
IN - India 46
NL - Olanda 34
CA - Canada 29
HK - Hong Kong 18
JP - Giappone 17
TR - Turchia 16
MA - Marocco 11
RU - Federazione Russa 11
AU - Australia 10
ES - Italia 9
ZA - Sudafrica 9
NG - Nigeria 8
BE - Belgio 7
CZ - Repubblica Ceca 5
GH - Ghana 5
ID - Indonesia 5
KR - Corea 5
NZ - Nuova Zelanda 5
BR - Brasile 4
ET - Etiopia 4
RO - Romania 4
SA - Arabia Saudita 4
CU - Cuba 3
EE - Estonia 3
EG - Egitto 3
HU - Ungheria 3
LT - Lituania 3
MD - Moldavia 3
PL - Polonia 3
AT - Austria 2
BG - Bulgaria 2
CH - Svizzera 2
CL - Cile 2
DJ - Gibuti 2
IR - Iran 2
PT - Portogallo 2
TH - Thailandia 2
TZ - Tanzania 2
UY - Uruguay 2
ZM - Zambia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BZ - Belize 1
CD - Congo 1
CO - Colombia 1
DK - Danimarca 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
LV - Lettonia 1
MM - Myanmar 1
MX - Messico 1
MY - Malesia 1
SC - Seychelles 1
TN - Tunisia 1
VE - Venezuela 1
Totale 27.543
Città #
Fairfield 3.999
Woodbridge 2.691
Houston 1.922
Ann Arbor 1.801
Ashburn 1.511
Chandler 1.399
Seattle 1.395
Cambridge 1.329
Wilmington 1.196
Singapore 864
Boardman 639
Princeton 484
Santa Clara 473
San Diego 471
Medford 367
Jacksonville 325
Des Moines 297
Roxbury 226
Helsinki 197
Nanjing 186
Padova 159
Dong Ket 158
Beijing 133
Ogden 63
London 60
Shenyang 60
Guangzhou 56
Dublin 55
Nanchang 53
Hebei 45
New York 44
Jiaxing 42
Milan 41
Norwalk 29
Tianjin 25
Kilburn 24
Rome 24
Falls Church 22
Lappeenranta 21
Kharkiv 19
Shanghai 19
Marseille 18
Hong Kong 17
Pune 17
Los Angeles 16
Fort Worth 15
Jinan 15
Borås 14
Changsha 13
New Bedfont 12
Toronto 12
Hounslow 11
Turin 11
Washington 11
Crevacuore 10
Dallas 10
Prescot 10
Chiswick 9
Rockville 9
Venice 9
Vicenza 9
Göttingen 8
Hangzhou 8
Indiana 8
Paris 8
Parma 8
Frankfurt am Main 7
Kenitra 7
Madrid 7
Moscow 7
Siena 7
Zhengzhou 7
Como 6
Council Bluffs 6
Islington 6
Legnaro 6
Redwood City 6
Tappahannock 6
Bergamo 5
Bologna 5
Kunming 5
Nanterre 5
Noblesville 5
Orange 5
Ottawa 5
San Francisco 5
San Stino di Livenza 5
Southwark 5
Taiyuan 5
Trento 5
Verona 5
Yenibosna 5
Auckland 4
Brussels 4
Chennai 4
Chicago 4
Durban 4
East Lansing 4
Empoli 4
Hefei 4
Totale 23.392
Nome #
Premature aging and immune senescence in HIV-infected children 147
Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020 138
Human Immunodeficiency Virus (HIV)-Antibody Repertoire Estimates Reservoir Size and Time of Antiretroviral Therapy Initiation in Virally Suppressed Perinatally HIV-Infected Children 137
Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV 136
Update on antiretroviral therapy in paediatrics. 131
Antibiotic prescriptions and prophylaxis in Italian children. Is it time to change? Data from the ARPEC project 128
Missed opportunities to prevent mother-to-child transmission of HIV in Italy 128
Hepatitis B virus infection in children and adolescents 128
Malaria prevention reduces in-hospital mortality among severely ill tuberculosis patients: a three-step intervention in Bissau, Guinea-Bissau. 125
Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children 123
Early and Highly Suppressive ART are Main Factors Associated with Low Viral Reservoir in European Perinatally HIV Infected Children 120
Severe haematologic toxicity is rare in high risk HIV-exposed infants receiving combination neonatal prophylaxis 118
Age-related standards for total lymphocyte, CD4(+) and CD8(+) T cell counts in children born in Europe 117
Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution. 117
The worldwide antibiotic resistance and prescribing in european children (ARPEC) point prevalence survey: Developing hospital-quality indicators of antibiotic prescribing for children 116
Accelerated aging in perinatally HIV-infected children: clinical manifestations and pathogenetic mechanisms 116
Pregnancy and Neonatal Outcomes Following Prenatal Exposure to Dolutegravir 116
Ocular involvement in an HIV-infected patient: not always an infectious disease. An interesting case without apparent cause 116
Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004-2005: The REVEAL study 113
Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection. 112
Comparing imported malaria in adults and children presenting to an Italian teaching hospital: A 10-year retrospective study 112
Hepatitis C virus infection in children and adolescents 112
Effects of an antimicrobial stewardship intervention on perioperative antibiotic prophylaxis in pediatrics 111
Vulvar carcinoma in a 12-year-old girl with vertically acquired human immunodeficiency virus infection 109
Antibiotics Prescriptions in the Neonatal Intensive Care Unit: How to Overcome Everyday Challenges 108
The Impact of Clinical Pathways on Antibiotic Prescribing for Acute Otitis Media and Pharyngitis in the Emergency Department 108
CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand 108
Prospective study of the burden of acute gastroenteritis and rotavirus gastroenteritis in children less than 5 years of age, in Padova, Italy 107
PRIMARY LYMPHOMA OF THE CENTRAL-NERVOUS-SYSTEM IN 2 CHILDREN WITH ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME 106
Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission 105
Italian consensus statement on paediatric HIV infection. 105
Is "option B+" also being adopted in pregnant women in high-income countries? Temporal trends from a national study in Italy 105
HIV-infected pregnant women and vertical transmission in Europe since 1986 104
High Rates of Prescribing Antimicrobials for Prophylaxis in Children and Neonates: Results From the Antibiotic Resistance and Prescribing in European Children Point Prevalence Survey 104
HIV-1 with Multiple CCR5/CXCR4 Chimeric Receptor Use Is Predictive of Immunological Failure in Infected Children 103
Risk factors for mother-to-child transmission of HIV-1. 103
Diagnosi eziologia delle polmoniti nel bambino immunocompresso 102
The immunological and virological consequences of planned treatment interruptions in children with HIV infection. 102
Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study 101
Impact of a vaccination programme in children vaccinated with ProQuad, and ProQuad-specific effectiveness against varicella in the Veneto region of Italy 101
A PROSPECTIVE STUDY ON THE INCIDENCE AND EVOLUTION ON OF CONGENITAL CMV INFECTION IN A URBAN ITALIAN COMMUNITY. 99
A new screening test for rotavirus infection 99
Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life 99
Predictors of faster virological suppression in early treated infants with perinatal HIV from Europe and Thailand 99
Programmatic impact of the evolution of WHO pediatric antiretroviral treatment guidelines for resource-limited countries (Tukula Fenna Project, Uganda). 98
Vaccine impact: Benefits for human health 97
Response to planned treatment interruptions in HIV infection varies across childhood 96
Antiretroviral treatment in pregnancy: a six-year perspective on recent trends in prescription patterns, viral load suppression, and pregnancy outcomes. 96
Regulatory T cells and chronic immune activation in human immunodeficiency virus 1 (HIV-1)-infected children 96
Rate, correlates and outcomes of repeat pregnancy in HIV-infected women 96
A randomized double-blinded trial of the addition of lamivudine or matching placebo to current nucleoside analogue reserve transcriptase inhibitor therapy in HIV-onfected children. The PENTA 4 trial. 95
Role of non-nucleoside reverse transcriptase inhibitors in treating HIV-infected children. 95
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. 95
Epidemiology of Frequently Occurring Skin Diseases in Italian Children from 2006 to 2012: A Retrospective, Population-Based Study 95
Combination antiretroviral therapy and duration of pregnancy 95
Acute infectious osteomyelitis in children: new treatment strategies for an old enemy 95
Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies. 94
Polymorphims of innate immunity genes influence disease progression in HIV-1 infected children 94
Increasing likelihood of further live births in HIV-infected women in recent years 94
Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness 93
Polymorphisms of innate immunity genes influence disease progression in HIV-1-infected children. 93
Age distribution of paediatric rotavirus gastroenteritis cases in Europe: the REVEAL study. 93
Raltegravir in HIV-1-infected pregnant women: Pharmacokinetics, safety, and efficacy 93
Levels and patterns of HIV RNA viral load in untreated pregnant women 92
Beta endorphin concentrations in human milk 92
The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women. 92
Distribution of rotavirus genotypes in Europe, 2004-2005: The REVEAL study 92
Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases 92
Osteomyelitis in Cat-Scratch Disease: A Never-Ending Dilemma-A Case Report and Literature Review 92
Early antiretroviral therapy in children perinatally infected with HIV: A unique opportunity to implement immunotherapeutic approaches to prolong viral remission 92
The value of open-source clinical science in pandemic response: lessons from ISARIC 91
Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers 91
HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. 91
PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection. 91
Time to switch to second-line antiretroviral therapy in children with human immunodeficiency virus in Europe and Thailand 91
Immunological markers in HIV-infected pregnant women. 90
Pediatric Drug Safety Surveillance in FDA-AERS: a description of adverse events from GRIP Project 90
The Challenge of Treating Children with Hepatitis C Virus Infection 90
A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: The PERA (PENTA 8) trial 89
Gender and race do not alter early-life determinants of clinical disease progression in HIV-1 vertically infected children. 88
Innovative study design for paediatric clinical trials. 88
An unexpected fever post serogroup B meningococcal sepsis 88
Detection of virus in vertically exposed HIV-antibody-negative children. 87
In-vitro production of HIV-specific antibody in children at risk of AIDS. 87
Voluntary pregnancy termination among women with HIV in the HAART era (2002-2008): a case series from a national study. 87
Sexual protection behavior in HIV-positive gay men: testing a modified information-motivation-behavioral skills model. 87
Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women 87
Infants born to mothers seropositive for human immunodeficiency virus. Preliminary findings from a multicentre European study. 86
Impact of community-acquired paediatric rotavirus gastroenteritis on family life: data from the REVEAL study. 86
Harmonisation in study design and outcomes in paediatric antibiotic clinical trials: a systematic review 86
Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers 86
Long-term decay of the HIV-1 reservoir in HIV-1-infected children treated with highly active antiretroviral therapy 85
Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. 85
Factors Determining Survival and Retention among HIV-Infected Children and Adolescents in a Community Home-Based Care and a Facility-Based Family-Centred Approach in Kampala, Uganda: A Cohort Study 85
Pathways of care for HIV infected children in Beira, Mozambique: pre-post intervention study to assess impact of task shifting 85
Biological Aging and Immune Senescence in Children with Perinatally Acquired HIV 85
Improvements in virological control among women conceiving on combination antiretroviral therapy in Western Europe. 84
Assessment of pediatric asthma drug use in three European countries; a TEDDY study. 84
Viral Load detection using dried blood spots in a cohort of HIV-1 infected children in Uganda: correlations with clinical and immunological criteria for treatment failure 84
Defining off-label and unlicensed use of medicines for children: Results of a Delphi survey 84
Totale 10.059
Categoria #
all - tutte 121.300
article - articoli 119.316
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 349
Totale 240.965


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.739 0 0 0 0 0 372 475 565 572 328 275 152
2020/20213.645 155 272 155 310 127 184 254 310 496 448 322 612
2021/20225.382 188 592 729 379 179 334 271 573 234 156 541 1.206
2022/20233.162 774 269 57 355 585 408 15 183 351 10 122 33
2023/20241.824 57 231 193 138 120 142 137 89 146 36 252 283
2024/20252.925 48 589 414 328 1.322 224 0 0 0 0 0 0
Totale 27.993